Transaction in Own Shares

For immediate release 30 November 2007 FINSBURY WORLDWIDE PHARMACEUTICAL TRUST PLC (the "Company") MARKET PURCHASE OF COMPANY'S OWN SHARES Notification is given, pursuant to the authority granted at the Annual General Meeting of the Company held on 9 July 2007 to make market purchases of the Company's own shares up to an aggregate maximum of 7,557,925, that a market total of 125,000 Ordinary shares of 25p each in the capital of the Company were purchased today by the Company at a price of 483.16p per share. Such shares will be cancelled. Following this transaction and in conformity with the Transparency Directive's transitional provision 6 the Company hereby notifies the market that: the total number of Ordinary shares held by the Company in treasury following the purchase is 5,192,100; and the total number of Ordinary shares that the Company has in issue, less the total number of Ordinary shares held by the Company in treasury following such purchase, and therefore, the total number of voting rights in the Company is 47,785,968. The figure of 47,785,968 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FSA's Disclosure and Transparency Rules. For and on behalf of Frostrow Capital LLP Company Secretary For further information, please contact: Mark Pope Frostrow Capital LLP Tel: 020 3 0084913
UK 100

Latest directors dealings